{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:45:19Z","timestamp":1789073119250,"version":"build-2803163510"},"update-to":[{"DOI":"10.1371\/journal.pntd.0006581","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T00:00:00Z","timestamp":1530576000000}}],"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T00:00:00Z","timestamp":1529539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000185","name":"Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["DARPA-BAA-13-03DD1144"],"award-info":[{"award-number":["DARPA-BAA-13-03DD1144"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0006581","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T13:54:46Z","timestamp":1529589286000},"page":"e0006581","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":54,"title":["Intranasal monkeypox marmoset model: Prophylactic antibody treatment provides benefit against severe monkeypox virus disease"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4656-5379","authenticated-orcid":true,"given":"Eric M.","family":"Mucker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9409-2756","authenticated-orcid":true,"given":"Suzanne E.","family":"Wollen-Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Kimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Shamblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darryl","family":"Sampey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay W.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,6,21]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1056\/NEJMoa032299","article-title":"The detection of monkeypox in humans in the Western Hemisphere","volume":"350","author":"KD Reed","year":"2004","journal-title":"The New England journal of medicine"},{"issue":"37","key":"ref2","doi-asserted-by":"crossref","first-page":"16262","DOI":"10.1073\/pnas.1005769107","article-title":"Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo","volume":"107","author":"AW Rimoin","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3201\/eid2206.150579","article-title":"Extended Human-to-Human Transmission during a Monkeypox Outbreak in the Democratic Republic of the Congo","volume":"22","author":"LD Nolen","year":"2016","journal-title":"Emerging infectious diseases"},{"issue":"8","key":"ref4","first-page":"658","article-title":"Emerging diseases-the monkeypox epidemic in the Democratic Republic of the Congo. Clinical microbiology and infection: the official publication of the","volume":"22","author":"A Kantele","year":"2016","journal-title":"European Society of Clinical Microbiology and Infectious Diseases"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1586\/14787210.2014.979157","article-title":"Discovery of forgotten variola specimens at the National Institutes of Health in the USA","volume":"12","author":"I. Arita","year":"2014","journal-title":"Expert review of anti-infective therapy"},{"key":"ref6","article-title":"The De Novo Synthesis of Horsepox Virus: Implications for Biosecurity and Recommendations for Preventing the Reemergence of Smallpox","author":"GD Koblentz","year":"2017","journal-title":"Health security"},{"issue":"7","key":"ref7","doi-asserted-by":"crossref","first-page":"e42353","DOI":"10.1371\/journal.pone.0042353","article-title":"Side-by-side comparison of gene-based smallpox vaccine with MVA in nonhuman primates","volume":"7","author":"JW Golden","year":"2012","journal-title":"PloS one"},{"issue":"39","key":"ref8","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1016\/j.vaccine.2013.03.020","article-title":"Clinical development of Modified Vaccinia virus Ankara vaccines","volume":"31","author":"SC Gilbert","year":"2013","journal-title":"Vaccine"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/infdis\/jir527","article-title":"Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults","volume":"204","author":"JS Kennedy","year":"2011","journal-title":"The Journal of infectious diseases"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"6246","DOI":"10.1128\/AAC.00977-13","article-title":"Efficacy of tecovirimat (ST-246) in nonhuman primates infected with variola virus (Smallpox)","volume":"57","author":"EM Mucker","year":"2013","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1128\/AAC.00904-12","article-title":"Safety and pharmacokinetics of the anti-orthopoxvirus compound ST-246 following a single daily oral dose for 14 days in human volunteers","volume":"56","author":"J Chinsangaram","year":"2012","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.antiviral.2017.01.009","article-title":"Short-term clinical safety profile of brincidofovir: A favorable benefit-risk proposition in the treatment of smallpox","volume":"143","author":"G Chittick","year":"2017","journal-title":"Antiviral research"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/viro.1995.1378","article-title":"A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies","volume":"211","author":"EJ Wolffe","year":"1995","journal-title":"Virology"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1073\/pnas.0510598103","article-title":"Chimpanzee\/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus","volume":"103","author":"Z Chen","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"19","key":"ref15","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1128\/JVI.78.19.10230-10237.2004","article-title":"Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions","volume":"78","author":"C Fogg","year":"2004","journal-title":"Journal of virology"},{"key":"ref16","first-page":"86","article-title":"Differences between extracellular and intracellular forms of poxvirus and their implications","volume":"16","author":"EA Boulter","year":"1973","journal-title":"Progress in medical virology Fortschritte der medizinischen Virusforschung Progres en virologie medicale"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/003591576906200349","article-title":"Protection against poxviruses","volume":"62","author":"EA Boulter","year":"1969","journal-title":"Proceedings of the Royal Society of Medicine"},{"issue":"21","key":"ref18","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1128\/JVI.79.21.13454-13462.2005","article-title":"Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge","volume":"79","author":"S Lustig","year":"2005","journal-title":"Journal of virology"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1128\/AAC.00021-09","article-title":"Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246","volume":"53","author":"J Huggins","year":"2009","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1128\/AAC.01596-08","article-title":"ST-246 antiviral efficacy in a nonhuman primate monkeypox model: determination of the minimal effective dose and human dose justification","volume":"53","author":"R Jordan","year":"2009","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"e0131742","DOI":"10.1371\/journal.pone.0131742","article-title":"Susceptibility of Marmosets (Callithrix jacchus) to Monkeypox Virus: A Low Dose Prospective Model for Monkeypox and Smallpox Disease","volume":"10","author":"EM Mucker","year":"2015","journal-title":"PloS one"},{"key":"ref22","article-title":"Enhanced expression of a biosimilar monoclonal antibody with a novel NS0 platform","author":"D Sampey","year":"2018","journal-title":"Biotechnology progress"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.virol.2007.06.042","article-title":"Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein","volume":"368","author":"HP Su","year":"2007","journal-title":"Virology"},{"key":"ref24","first-page":"1460","article-title":"its eradication","volume":"xvi","author":"Fenner F. Smallpox","year":"1988"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1017\/S0950268806007618","article-title":"Infectiousness of smallpox relative to disease age: estimates based on transmission network and incubation period","volume":"135","author":"H Nishiura","year":"2007","journal-title":"Epidemiology and infection"},{"key":"ref26","first-page":"49","article-title":"Studies on the virus content of mouth washings in the acute phase of smallpox","volume":"25","author":"AW Downie","year":"1961","journal-title":"Bulletin of the World Health Organization"},{"issue":"5","key":"ref27","first-page":"523","article-title":"Virus excretion in smallpox. 2. Excretion in the throats of household contacts","volume":"48","author":"JK Sarkar","year":"1973","journal-title":"Bulletin of the World Health Organization"},{"issue":"5","key":"ref28","first-page":"517","article-title":"Virus excretion in smallpox. 1. Excretion in the throat, urine, and conjunctiva of patients","volume":"48","author":"JK Sarkar","year":"1973","journal-title":"Bulletin of the World Health Organization"},{"issue":"1\u20132","key":"ref29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF01313742","article-title":"Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus","volume":"108","author":"RO Jacoby","year":"1989","journal-title":"Archives of virology"},{"key":"ref30","first-page":"91","article-title":"Insufficient Innate Immunity Contributes to the Susceptibility of the Castaneous Mouse to Orthopoxvirus Infection","author":"PL Earl","year":"2017","journal-title":"Journal of virology"},{"issue":"17","key":"ref31","doi-asserted-by":"crossref","first-page":"9105","DOI":"10.1128\/JVI.00162-12","article-title":"Lethal monkeypox virus infection of CAST\/EiJ mice is associated with a deficient gamma interferon response","volume":"86","author":"PL Earl","year":"2012","journal-title":"Journal of virology"},{"issue":"8","key":"ref32","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/infdis\/jiq162","article-title":"Smallpox vaccine safety is dependent on T cells and not B cells","volume":"203","author":"SN Gordon","year":"2011","journal-title":"The Journal of infectious diseases"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1172\/JCI38506","article-title":"Control of vaccinia virus skin lesions by long-term-maintained IFN-gamma+TNF-alpha+ effector\/memory CD4+ lymphocytes in humans","volume":"120","author":"B Puissant-Lubrano","year":"2010","journal-title":"The Journal of clinical investigation"},{"issue":"25\u201326","key":"ref34","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1016\/j.vaccine.2009.01.086","article-title":"Gender effects on humoral immune responses to smallpox vaccine","volume":"27","author":"RB Kennedy","year":"2009","journal-title":"Vaccine"},{"issue":"41","key":"ref35","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1016\/j.vaccine.2015.08.032","article-title":"Sex difference in immune response to vaccination: A participant-level meta-analysis of randomized trials of IMVAMUNE smallpox vaccine","volume":"33","author":"JD Troy","year":"2015","journal-title":"Vaccine"},{"key":"ref36","unstructured":"Mucker E. Remodeling smallpox in nonhuman primates. Ph.D. Dissertation, Tulane University. 2014. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/search.proquest.com\/openview\/5cf3258fc67e6a4a2d28350efd49ecaa\/1?pq-origsite=gscholar&cbl=18750&diss=y\" xlink:type=\"simple\">https:\/\/search.proquest.com\/openview\/5cf3258fc67e6a4a2d28350efd49ecaa\/1?pq-origsite=gscholar&amp;cbl=18750&amp;diss=y<\/ext-link>"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0006581","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T00:00:00Z","timestamp":1530576000000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0006581","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T16:50:56Z","timestamp":1571503856000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0006581"}},"subtitle":[],"editor":[{"given":"Thomas","family":"Geisbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,6,21]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0006581","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0006581","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,21]]}}}